Stock listing
OMXICE:OCS Oculis Holding AG Hlutabréf
Icelandic listing (OMXICE) of Oculis Holding AG · home listing NASDAQ:OCS
Follow Oculis Holding AG into a list and get an email when it puts out news.
Home listing price · NASDAQ:OCS
$7.63 USD -0.08 (-1.0%)
Close on Nov 3, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:OCS
- Day range
- $7.29 – $7.87 USDNov 3, 2026
- Volume
- 541,787 sharesNov 3, 2026
- Market cap
- $469.9M USDAt the close on Nov 3, 2026 · price × 61.59M shares outstanding
- 52-week range
- $7.11 – $34.48 USDLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
- Traded on an average day
- $2.59M USDMedian day 240,800 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:OCS · Home | $7.63 USD | -0.08 (-1.0%) | 541,787 | $7.72 | $7.87 | $7.29 | $7.71 | Close on Nov 3, 2026 |
| Frankfurt:CR5 | €6.50 EUR | -0.30 (-4.4%) | — | €6.70 | €6.90 | €6.50 | €6.80 | Close on Oct 26, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 3, 2026 · NASDAQ:OCS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $7.63 | -0.08 | -1.0% | $7.72 | $7.87 | $7.29 | 541,787 | |
| $7.71 | -0.55 | -6.7% | $8.38 | $8.539 | $7.66 | 246,350 | |
| $8.26 | +0.02 | +0.2% | $8.19 | $8.84 | $8.19 | 309,697 | |
| $8.24 | +0.26 | +3.3% | $8.09 | $8.53 | $8.09 | 263,708 | |
| $7.98 | +0.15 | +1.9% | $7.80 | $8.05 | $7.72 | 219,995 | |
| $7.83 | -0.13 | -1.6% | $7.92 | $8.145 | $7.68 | 189,294 | |
| $7.96 | +0.06 | +0.8% | $7.88 | $8.025 | $7.66 | 206,964 | |
| $7.90 | -0.19 | -2.3% | $8.04 | $8.07 | $7.82 | 294,700 | |
| $8.09 | +0.22 | +2.8% | $7.77 | $8.31 | $7.725 | 427,600 | |
| $7.87 | +0.38 | +5.1% | $7.54 | $8.02 | $7.40 | 324,100 | |
| $7.49 | +0.17 | +2.3% | $7.29 | $7.79 | $7.285 | 318,700 | |
| $7.32 | +0.03 | +0.4% | $7.25 | $7.46 | $7.15 | 288,400 | |
| $7.29 | -0.11 | -1.5% | $7.33 | $7.46 | $7.16 | 293,700 | |
| $7.40 | +0.23 | +3.2% | $7.25 | $7.60 | $7.15 | 559,200 | |
| $7.17 | -0.45 | -5.9% | $7.51 | $7.74 | $7.11 | 511,400 | |
| $7.62 | -0.26 | -3.3% | $7.84 | $7.84 | $7.32 | 320,200 | |
| $7.88 | -0.46 | -5.5% | $8.27 | $8.325 | $7.85 | 283,600 | |
| $8.34 | -0.32 | -3.7% | $8.60 | $8.75 | $8.30 | 161,900 | |
| $8.66 | +0.16 | +1.9% | $8.50 | $8.75 | $8.37 | 452,000 | |
| $8.50 | -0.22 | -2.5% | $8.83 | $8.83 | $8.35 | 173,700 | |
| $8.72 | +0.16 | +1.9% | $8.61 | $8.80 | $8.30 | 291,600 | |
| $8.56 | -0.17 | -1.9% | $8.79 | $9.00 | $8.56 | 242,000 | |
| $8.73 | -0.03 | -0.3% | $8.82 | $8.825 | $8.53 | 586,300 | |
| $8.76 | -0.58 | -6.2% | $9.16 | $9.26 | $8.67 | 578,400 | |
| $9.34 | +0.21 | +2.3% | $9.20 | $9.48 | $9.02 | 434,700 | |
| $9.13 | +0.07 | +0.8% | $9.10 | $9.38 | $9.07 | 373,400 | |
| $9.06 | -0.21 | -2.3% | $9.20 | $9.33 | $9.00 | 267,000 | |
| $9.27 | -0.14 | -1.5% | $9.71 | $9.71 | $9.10 | 239,600 | |
| $9.41 | -0.58 | -5.8% | $9.94 | $9.945 | $9.21 | 209,200 | |
| $9.99 | -0.72 | -6.7% | $10.64 | $10.77 | $9.88 | 143,800 | |
| $10.71 | +0.57 | +5.6% | $10.27 | $10.84 | $10.26 | 206,700 | |
| $10.14 | 0.00 | 0.0% | $10.19 | $10.35 | $10.00 | 201,800 | |
| $10.14 | +0.16 | +1.6% | $10.17 | $10.43 | $9.67 | 412,000 | |
| $9.98 | +0.07 | +0.7% | $9.90 | $10.16 | $9.85 | 248,000 | |
| $9.91 | -0.16 | -1.6% | $10.11 | $10.20 | $9.65 | 313,900 | |
| $10.07 | -0.53 | -5.0% | $10.60 | $10.61 | $10.00 | 159,300 | |
| $10.60 | +0.04 | +0.4% | $10.56 | $10.84 | $10.51 | 153,200 | |
| $10.56 | -0.75 | -6.6% | $11.39 | $11.98 | $10.50 | 226,600 | |
| $11.31 | -0.16 | -1.4% | $11.34 | $11.60 | $11.00 | 169,300 | |
| $11.47 | -0.69 | -5.7% | $12.11 | $12.13 | $11.40 | 162,300 | |
| $12.16 | -0.01 | -0.1% | $12.09 | $12.24 | $11.93 | 138,600 | |
| $12.17 | 0.00 | 0.0% | $12.07 | $12.66 | $11.93 | 124,300 | |
| $12.17 | +0.15 | +1.2% | $12.10 | $12.29 | $11.96 | 179,200 | |
| $12.02 | -0.16 | -1.3% | $12.20 | $12.40 | $11.95 | 183,100 | |
| $12.18 | -0.07 | -0.6% | $12.17 | $12.29 | $12.02 | 83,400 | |
| $12.25 | +0.04 | +0.3% | $12.11 | $12.34 | $11.99 | 114,100 | |
| $12.21 | -0.22 | -1.8% | $12.38 | $12.50 | $12.14 | 221,900 | |
| $12.43 | -0.54 | -4.2% | $12.88 | $13.12 | $12.42 | 111,300 | |
| $12.97 | +0.01 | +0.1% | $12.98 | $13.06 | $12.81 | 161,900 | |
| $12.96 | -0.22 | -1.7% | $13.25 | $13.42 | $12.90 | 192,367 | |
| $13.18 | +0.095 | +0.7% | $13.10 | $13.25 | $12.87 | 150,387 | |
| $13.09 | -0.055 | -0.4% | $13.17 | $13.28 | $13.00 | 76,500 | |
| $13.14 | -0.43 | -3.2% | $13.41 | $13.54 | $13.04 | 111,200 | |
| $13.57 | +0.38 | +2.9% | $13.21 | $13.70 | $13.15 | 272,000 | |
| $13.19 | +0.05 | +0.4% | $13.07 | $13.20 | $12.89 | 198,900 | |
| $13.14 | +0.20 | +1.5% | $12.86 | $13.34 | $12.80 | 220,200 | |
| $12.94 | +0.12 | +0.9% | $12.84 | $13.09 | $12.52 | 125,400 | |
| $12.82 | -0.07 | -0.5% | $12.87 | $13.19 | $12.64 | 193,300 | |
| $12.89 | +0.14 | +1.1% | $12.91 | $13.25 | $12.83 | 253,200 | |
| $12.75 | -0.01 | -0.1% | $12.85 | $12.90 | $12.51 | 143,125 | |
| $12.76 | +0.08 | +0.6% | $12.31 | $12.90 | $12.31 | 287,343 | |
| $12.68 | +0.30 | +2.4% | $12.95 | $13.28 | $12.41 | 370,900 | |
| $12.38 | +0.31 | +2.6% | $11.96 | $12.51 | $11.82 | 264,900 | |
| $12.07 | +0.08 | +0.7% | $12.10 | $12.42 | $11.87 | 579,300 | |
| $11.99 | +0.10 | +0.8% | $12.07 | $12.36 | $11.89 | 311,000 | |
| $11.89 | +0.58 | +5.1% | $11.95 | $12.15 | $11.67 | 295,700 |
- Ticker
- OMXICE:OCS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OMXICE
- Currency
- ISK
What changed lately
Latest news release · Nov 3, 2026
Oculis Reports Q3 2026 Financial Results and Builds Momentum Toward Multiple Upcoming Pipeline Catalysts
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 43 slides
Latest news
Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation
Nov 2, 2026
Closed $7.71 (-6.7%) on Nov 2, 2026
Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit
Oct 29, 2026
Closed $8.24 (+3.3%) on Oct 29, 2026
Oculis Reports New Phase 2 ACUITY Biomarker Data Further Supporting Privosegtor’s Neuroprotective Potential in Optic Neuritis
Oct 22, 2026
Closed $8.09 (+2.8%) on Oct 22, 2026
Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting
Oct 20, 2026
Closed $7.49 (+2.3%) on Oct 20, 2026
Oculis lýkur slembiröðun í PREDICT-1 skráningarrannsókninni á Licaminlimab við TNFR1-miðluðum augnþurrki
Oct 19, 2026
Closed $7.32 (+0.4%) on Oct 19, 2026
Oculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Disease
Oct 19, 2026
Closed $7.32 (+0.4%) on Oct 19, 2026
Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day
Oct 7, 2026
Closed $8.50 (-2.5%) on Oct 7, 2026
Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS
Oct 1, 2026
Closed $8.76 (-6.2%) on Oct 1, 2026
Oculis Announces Resignation of Lionel Carnot from Board of Directors
Sep 30, 2026
Closed $8.76 (-6.2%) on Oct 1, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 43 slides · September 2026
Investor Presentation (June 2026)
Investor deck · 28 slides · Jun 25, 2026
Technical Presentation (May 2026)
Technical · 17 slides · May 29, 2026
Shareholder Meeting (May 2026)
Shareholder meeting · 11 slides · May 13, 2026
Oculis Holding AG on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 36 in the last 12 months · 125 in all · newest Nov 3, 2026 · oldest 2023
- Decks
- 15 decks · latest September 2026
Where Oculis Holding AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:OCS · Home listing | NASDAQ | United States | USD |
| OMXICE:OCS · This page | OMXICE | Iceland | ISK |
| LS Exchange:A3D8QG | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3D8QG | Lang & Schwarz | Germany | EUR |
| Stuttgart:CR5 | Stuttgart | Germany | EUR |
| Frankfurt:CR5 | Frankfurt | Germany | EUR |
| BOATS:OCS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Oculis Holding AG.